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Abstract
Background The clinical practice of using carbon dioxide
therapy for localized adiposities was audited over a 4-year
period.
Methods Patients receiving physical, dietary, or drug
concurrent therapy were excluded from the audit. Original
measurements in terms of mean ± standard error of the
mean (SEM) were compared with those obtained after ﬁve
sessions.
Results This series included 101 women who underwent
abdominal therapy. Signiﬁcant reduction (p\0.05) in
mean upper, mid, and lower abdomen circumference
was experienced by all three age groups: respectively,
1.8 ± 0.5, 1.6 ± 0.4, and 2.1 ± 0.3 cm in the 20- to 29-
year- old group, 1.6 ± 0.4, 2.3 ± 0.3, and 2.1 ± 0.3 cm in
the 30- to 39-year-old group, and 2.0 ± 0.4, 2.5 ± 0.4, and
2.6 ± 0.4 cm in the 40- to 50-year-old group. For 57
women who underwent localized thigh therapy (27 in the
20- to 29-year-old group, 18 in the 30- to 39-year-old
group, and 12 in the 40- to 50-year-old group), thigh cir-
cumference was signiﬁcantly reduced in the right versus
left thigh: respectively, 1.6 ± 0.3 versus 1.5 ± 0.2 cm,
1.1 ± 0.3 versus 1.1 ± 0.3 cm, 1.6 ± 0.3 versus 1.5 ±
0.4. Weight loss was signiﬁcant for older women who
underwent abdominal therapy: 1.3 ± 0.2 kg in the 30- to
39-year-old group (n = 43) and 1.3 ± 0.2 kg in the 40- to
50 year-old group (n = 29). Older women who underwent
thigh therapy also recorded signiﬁcant weight reduction:
0.9 ± 0.4 kg in the 30- to 39-year-old group (n = 18) and
1.6 ± 0.3 kg in the 40- to 50-year-old group (n = 12). The
results for 10 men were not signiﬁcant.
Conclusion These results agree with those reported
originally and demonstrate that carboxytherapy is safe and
effective.
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Carbon dioxide (CO2) therapy or carboxytherapy is the
transcutaneous administration of CO2 for therapeutic pur-
poses. Since Brandi et al. [1] described the efﬁcacy of CO2
in treating localized adiposities, showing measurable
reductions in maximum circumferences of the abdomen,
thigh, and knee regions, there has been a worldwide
interest in the treatment [2, 3]. In the same paper, Brandi
et al. [1] provided histologic evidence for the effects of
CO2 gas inﬁltration on subdermal adipose tissue. Brandi
et al. [4] subsequently reported improved skin elasticity
when carboxytherapy was performed for skin irregularity
after liposuction.
In this report we describe an audit of the results after
carboxytherapy for the treatment of cellulite over a 4-year
period (March 2004–2008) in our clinic.
Patients and Methods
Patients
The inclusion criteria for the study speciﬁed patients
undergoing a minimum of ﬁve carboxytherapy sessions at
1- to 2-week intervals who were not under special dietary
restrictions, not taking diet pills, and not undergoing other
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traindications to participation in the study included phle-
bitis; signiﬁcant cardiac, respiratory, renal, or hepatic
impairment; uncontrolled hypertension; and pregnancy.
Some patients treated for abdominal fat reduction under-
went ultrasound examination to document the presence of
subepidermal cellulite.
Methods
Carbon dioxide was infused subcutaneously into the
affected areas using the Carbomed Programmable Auto-
matic Carbon Dioxide Therapy apparatus (Carbossiterapia
Italiana S.R.L, Via Zanella, MI, Italy) and 30 gauge,
0.3 9 13-microlance needles (Fig. 1). The depth of infu-
sion was 10 to 13 mm. The device, calibrated to measure
the dosage in milliliters, regulated the ﬂow rate and the
infusion pressure. The infusion was administered at a
velocity of 50 to 100 ml/min, and the total quantity of CO2
infused was 500 to 1,000 ml for the abdomen and 800 to
1,000 ml for each thigh over a 20- to 30-min period. The
therapy was continuously monitored by qualiﬁed medical
personnel.
Measurements
Weight, abdominal, and thigh circumference measure-
ments were recorded at baseline and after each treatment
session. Abdominal circumferences were recorded at the
levels of the upper abdomen (5 cm above the umbilicus),
the mid abdomen (at the umbilicus), and the lower abdo-
men (5 cm below the umbilicus). Ultrasound measurement
of subcutaneous fat thickness was taken immediately
below the umbilicus for all patients undergoing abdominal
treatments. Maximum circumferences of both the right and
left sides of the thigh were recorded. The level of the thigh
circumference measurement was recorded as the distance
from the anterior superior iliac spine, and subsequent
measurements were taken from the same level for each
patient.
Analysis
The patients were grouped according to age (20- to
29-year-old group, 30- to 39-year-old group, and 40- to
50-year-old group), sex, and type of therapy. Measure-
ments at baseline and 2 weeks after the ﬁfth carbon dioxide
therapy session were compared in terms of mean ± stan-
dard error of the mean (SEM) using Student’s t test.
Signiﬁcance was set at a p value less than 0.05.
Results
A total of 101 women underwent abdominal therapy
(Table 1). A signiﬁcant reduction in upper, mid, and lower
abdomen circumference occurred in all three age groups:
respectively, 1.8 ± 0.5, 1.6 ± 0.4, and 2.1 ± 0.3 cm in the
20- to 29-year-old group, 1.6 ± 0.4, 2.3 ± 0.3, and
2.1 ± 0.3 cm in the 30- to 39-year-old group, and
2.0 ± 0.4, 2.5 ± 0.4, and 2.6 ± 0.4 cm in the 40- to
50-year-old group. For the 10 men who underwent the
same therapy, the fall in abdominal circumference was not
signiﬁcant. For the 57 women who underwent thigh ther-
apy (27 in the 20- to 29-year-old group, 18 in the 30- to 39-
year-old group, and 12 in the 40- to 50-year-old group),
thigh circumference was signiﬁcantly reduced respectively
in the right versus left thigh 1.6 ± 0.3 versus 1.5 ±
0.2 cm, 1.1 ± 0.3 versus 1.1 ± 0.3 cm, and 1.6 ± 0.3
versus 1.5 ± 0.4 cm.
Weight loss was signiﬁcant (Table 2) for the older
women who underwent abdominal therapy: 1.3 ± 0.2 kg
in the 30- to 39-year-old group (n = 43) and 1.3 ± 0.2 kg
in the 40- to 50-year-old group (n = 29). Older women
who underwent thigh therapy also recorded signiﬁcant
weight reduction: 0.9 ± 0.4 kg in the 30- to 39-year-old
group (n = 18) and 1.6 ± 0.3 kg in the 40- to 50-year-old
group (n = 12). Figure 2 shows the typical ultrasound
evidence of decreased subepidermal thickness after ﬁve
sessions of carboxytherapy.
Complications
The complications were minor and included pain at the
injection site as well as crepitus and minor aches, which
did not last more than 30 min. Some needle-entry bruising
was noted, which resolved within 7 to 10 days. No other
side effects were observed. Fig. 1 Front panel of the Carbomed Programmable (CO2) apparatus
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The women experienced a signiﬁcant reduction in
abdominal and thigh circumference. This was not reﬂected
in the male group, probably because of the group was small
(n = 10). The magnitude of the reduction (*2 cm) was
similar to that originally reported by Brandi et al. [1]i n
their prospective study of 48 women (all had thigh therapy
and 14 also had abdominal treatment) who underwent
carboxytherapy using the same equipment as in the current
series. This comparison is valid because we also excluded
all patients receiving concurrent drug or dietary treatment
to avoid any confounding factors.
Weight loss is not the primary objective of carboxy-
therapy, which is aimed at treating localized adiposities
and improving skin texture. However, women 30 to
50 years of age reported a small (*1 kg) but signiﬁcant
weight loss after abdominal or thigh carboxytherapy. This
supports the hypothesis that the site of CO2 action is
restricted to localized tissue [1, 6].
Complications
No serious complications from carboxytherapy have been
reported, as evidenced in this audit. This is hardly sur-
prising because CO2 is widely used in medicine as the
mainstay of minimally invasive surgery. During laparo-
scopic procedures, CO2 is routinely used inside body
cavities to provide a superb view and access for the ever-
growing list of surgical procedures. Hypercapnia, which
Table 1 Change in the measurements of 101 women (F) and 10 men (M)
a,b
Age (years) 20–29 30–39 40–50
Before After Before After Before After
Upper abdomen (F)
c (cm) 73.7 ± 7.1 71.9 ± 6.6 76.3 ± 7.3 74.7 ± 7.2 79.9 ± 7.0 78.0 ± 9.3
Mid abdomen (F)
c (cm) 79.9 ± 7.0 78.3 ± 6.0 83.3 ± 7.5 81.0 ± 7.5 85.0 ± 8.1 82.5 ± 7.3
Lower abdomen (F)
c (cm) 85.9 ± 6.9 83.7 ± 6.6 88.7 ± 7.0 86.6 ± 6.5 91.6 ± 8.0 89.0 ± 8.1
Upper abdomen (M)
d (cm) 82.8 ± 4.5 79.3 ± 3.5 88.5 ± 6.7 86.2 ± 5 108.5 ± 16.2 104 ± 15.6
Mid abdomen (M)
d (cm) 85.3 ± 1.8 82.5 ± 2.1 90.7 ± 5.3 88.6 ± 4.5 106.5 ± 15.6 104.5 ± 16.3
Lower abdomen (M)
d (cm) 86.3 ± 1.8 84.0 ± 1.4 92.4 ± 5.3 89.0 ± 3.3 105.3 ± 16 103.5 ± 16.3
Right thigh (F)
e (cm) 55.1 ± 4.4 53.6 ± 4.1 54.3 ± 4.1 53.2 ± 3.9 58.2 ± 6.2 56.6 ± 5.7
Left thigh (F)
e (cm) 55.0 ± 4.3 53.6 ± 4.0 53.9 ± 4.3 52.8 ± 3.7 57.5 ± 6.3 56.0 ± 5.8
a Values are mean ± standard deviation
b Upper abdomen (5 cm above umbilicus), mid abdomen (at umbilicus), lower abdomen (5 cm below umbilicus)
c Change in abdominal girth for the following female groups: 20- to 29-year-old group (29 women), 30- to 39-year old group (43 women), 40- to
50-year-old group (29 women) (p\0.05)
d Change in abdominal girth for the following male groups: 20- to 29-year-old group (3 men), 30- to 39-year old group (5 men), 40- to 50-year-
old group (2 men)
e Change in thigh circumference for 57 women: 27 in the 20- to 29-year-old group, 18 in the 30- to 39-year-old group, and 12 in the 40- to
50-year-old group (p\0.05)
Table 2 Change in the weight of 101 women (F) and 10 men (M)
a
Age (years) 20–29 30–39 40–50
Before After Before After Before After
Abdomen (F)
b (kg) 53.9 ± 9.9 53.0 ± 9.5 56.2 ± 9.4
c 54.9 ± 9.2
c 58.6 ± 10.7
c 57.8 ± 10.7
c
Abdomen (M)
d (kg) 64.3 ± 3.3 64.2 ± 3.0 74.3 ± 8.7 74.3 ± 7.9 87.6 ± 43.6 87.5 ± 40.4
Thigh (F)
e (kg) 53.7 ± 7.6 53.2 ± 7.3 51.9 ± 8.0
c 51.0 ± 6.9
c 58.2 ± 6.1
c 56.6 ± 5.6
c
a Values are mean ± standard deviation
b Change in weight after abdominal therapy for the female groups: 20- to 29-year-old group (29 women), 30- to 39-year-old group (43 women),
and 40- to 50-year-old group (29 women)
c p\0.05
d Change in weight after abdominal therapy for the male groups: 20- to 29-year-old group (3 men), 30- to 39-year-old group (5 men), and 40- to
50-year-old group (2 men)
e Change in weight after thigh therapy for 57 women: 27 in the 20- to 29-year-old-group, 18 in the 30- to 39-year-old group, and 12 in the 40- to
50-year-old group
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very well tolerated. The equipment used in this study is
manufactured in Italy and approved by the European
Community (EC) for medical use.
Mechanism of Action
Sound physiologic principles underlie the possible mech-
anisms of CO2 action, modulating its effects on the skin
and subdermal layers. In a histologic study, Brandi et al.
[1] reported fracturing of the adipose tissue with release of
triglycerides in the intercellular spaces and adipocytes
presenting thin fracture lines in the plasma membrane.
These lines did not involve the connective spaces where the
major vascular structures are located. The dermis presented
a thicker appearance than before the treatment, with the
collagen ﬁbers distributed more diffusely.
Thesameauthorsreportedmicrocirculatorychangesafter
CO2 therapy, reﬂected by increased perfusion as measured
by laser Doppler ﬂowmetry and increased oxygen tension as
measured by transcutaneous oxygen tension. This is to be
expected from the Bohr effect on the oxygen dissociation
curve. Ferreira et al. [6], in a blind, interventional, cross-
sectional study, investigated CO2 injection in the dermis of
Wistarrats.Treatedratsshowedintensecollagenturnoverin
theirskinsamplescomparedwithcontrolanimals,whichhad
saline injections. These ﬁndings support the subjective
clinical ﬁndings of improved skin texture after CO2 therapy.
Cellulite
Obesity is associated with decreased self-esteem and
increased risk of diabetes and cardiovascular complications
such as hypertension and ischemic heart disease. In a
recent metaanalysis of 10 studies [8], the waist-to-height
ratio, an index of abdominal obesity, was found to be a
better discriminator of cardiovascular risk than body mass
index (BMI). Besides liposuction, the direct therapeutic
options for dealing with abdominal fat are few. Based on
our results, carboxytherapy, singly or in combination, is
deﬁnitely useful in this context.
Subjective Beneﬁts
One of the main problems of applying evidence-based
medicine to aesthetics is that the beneﬁts are subjective and
difﬁcult to quantify. Carboxytherapy is no exception
because the main attraction of this treatment is improve-
ment in skin texture and elasticity [1, 2]. Brandi et al. [4]
reported improved skin elasticity after carboxytherapy, as
measured by the Cutometer SEM 474 Courage-Khazaka
(CK Electronics, Koln, Germany) [9–11]. This ﬁnding has
been conﬁrmed by the recent development of an animal
model whereby increased collagen turnover was demon-
strated histologically [6].
Sex and Age Differences
Our data show the beneﬁts of carboxytherapy to be limited
for men. Although this can be explained by the lack of
sufﬁcient male patients (n = 10), sexual dimorphism in the
subdermal connective tissue is well documented [1]. This
consists of a different orientation in the sexes of the sub-
cutaneous ﬁbers, which extend from the dermis to the
fascia, probably linked to hormonal causes [12–14].
Younger women (age, 20–29 years) appear to derive less
objective beneﬁt from carboxytherapy. This supports the
view that cellulite increases with age and hence the beneﬁts
of carbon dioxide therapy are more quantiﬁable.
Clinical Practice
Consumer satisfaction is reﬂected in the widespread
acceptance of carboxytherapy worldwide [2, 3]. Clearly,
Fig. 2 Ultrasound examination of the abdomen showing measure-
ment of subcutaneous fat before (a) and after (b) carbon dioxide (CO2)
therapy. Subepidermal thickness is reduced after carboxytherapy
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123patients who enroll in wellness programs receive thorough
counseling. In our practice, patients undergo basic health
screening, and most patients receive concurrent dietary,
lifestyle, and exercise therapies. As part of a holistic
approach, CO2 and drug treatment may be added. An audit
of CO2 therapy should exclude the majority of patients who
enroll in a holistic program. Difﬁculty restricting mono-
therapy in clinical practice probably explains why pub-
lished audits of this popular treatment are few. Conversely,
it is likely that this audit may underestimate the results
because physical, drug, or dietary methods are excluded.
Conclusion
The results of this audit agree with those reported in
smaller prospective series, conﬁrming that carboxytherapy
is safe and effective.
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